• Skip to primary navigation
  • Skip to main content

National Forum

  • Home
  • About
    • Advisory Leadership Council
    • Board of Directors
    • 2023-24 Strategic Plan
    • History
    • National Forum Awards
    • Team
    • Support
    • Careers
  • Collaborations
    • Awareness Months 2023
    • Community Pharmacists
    • Counter Cholesterol™
    • Flu Prevention
    • Know Your Numbers
    • Million Hearts®
      • Million Hearts® Stakeholders Flu Vaccination Campaign ’22
    • Move with the Mayor™
    • Signature Reports
    • Stronger Hearts™
    • Value & Access
    • Value & Innovation Forum
  • Events
    • National Forum and Member Events
    • 2023 Annual Meeting
    • 2023 Mid-Year Virtual Convening
    • Health Equity Benefits Everyone – January 2023
    • Heart Failure Roundtable
    • Value & Innovation Forum
    • Meeting Archives
      • 2022 Annual Meeting
      • 2022 Mid-Year Virtual Convening
      • 2021 Annual Meeting
      • 2021 Mid-Year Virtual Convening
      • 2020 Annual Meeting
      • 2020 Mid-Year Meeting
      • 2019 Annual Meeting
      • 2019 Virtual Convening on Stroke
      • 2019 Mid-Year Member Meeting
      • 2018 Annual Meeting
      • 2018 Mid Year Meeting
  • Members
    • Membership
  • Newsroom
  • Search Toggle
  • Skip to content

ICER responds to the National Forum’s recommendation on cholesterol therapy update

Posted on 04.14.17

Letter to Mr. Matt Seidner, Program Manager, Institute for Clinical and Economic Review

Categories: Value & Access

1150 Connecticut Ave., NW, Suite 300, Washington, DC 20036
Phone: (866) 894-3500 Fax: (202) 330-5080
  • Legal
  • Sitemap
Copyright © 2023 National Forum for Heart Disease & Stroke Prevention. All Rights Reserved
  • Facebook
  • Twitter
  • YouTube
Contact

"*" indicates required fields

Name * Required
This field is for validation purposes and should be left unchanged.